Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Pharmaceuticals
The University of Texas MD Anderson Cancer Center will purchase Bellicum Pharmaceuticals’ approximately 5,500 m2 cell therapy facility in Houston, including manufacturing, office, and lab space, for $15 million. MD Anderson will operate the facility both for its own internal programs and to manufacture Bellicum’s GoCAR and other cell therapies for clinical trials and potentially early commercial supply. Bellicum says the deal will allow it to reduce expenses while keeping access to product supply.
This article has been sent to the following recipient: